vs

Side-by-side financial comparison of iSpecimen Inc. (ISPC) and REZOLVE AI PLC (RZLV). Click either name above to swap in a different company.

REZOLVE AI PLC is the larger business by last-quarter revenue ($1.2M vs $713.1K, roughly 1.7× iSpecimen Inc.). iSpecimen Inc. runs the higher net margin — -146.9% vs -1078.8%, a 931.9% gap on every dollar of revenue.

Specimen Products is a Chicago-based manufacturer of custom guitars, tube amplifiers, and audio horn speakers led by luthier Ian Schneller. Specimen Products also offers courses in guitar and tube amplifier design, construction, and repair through their Chicago School of Guitar Making. The Specimen workshop offers repair services to the general public, making use of their collection of parts from rare and vintage manufacturers.

REZOLVE AI PLC is a UK-based technology firm developing AI-powered mobile engagement and instant transaction platforms. Its solutions let consumers complete purchases directly from audio, video, and print content, serving retail, consumer goods, and media clients across Europe, North America, and select APAC markets.

ISPC vs RZLV — Head-to-Head

Bigger by revenue
RZLV
RZLV
1.7× larger
RZLV
$1.2M
$713.1K
ISPC
Higher net margin
ISPC
ISPC
931.9% more per $
ISPC
-146.9%
-1078.8%
RZLV

Income Statement — Q2 FY2025 vs Q2 FY2025

Metric
ISPC
ISPC
RZLV
RZLV
Revenue
$713.1K
$1.2M
Net Profit
$-1.0M
$-13.0M
Gross Margin
44.4%
Operating Margin
-255.4%
-808.4%
Net Margin
-146.9%
-1078.8%
Revenue YoY
-75.1%
Net Profit YoY
50.3%
EPS (diluted)
$-0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISPC
ISPC
RZLV
RZLV
Q2 25
$713.1K
$1.2M
Q1 25
$1.1M
Q4 24
$1.5M
Q3 24
$2.7M
Q2 24
$2.9M
Q1 24
$2.3M
Q4 23
$2.6M
Q3 23
$2.8M
Net Profit
ISPC
ISPC
RZLV
RZLV
Q2 25
$-1.0M
$-13.0M
Q1 25
$-1.7M
Q4 24
$-6.0M
Q3 24
$-1.4M
Q2 24
$-2.1M
Q1 24
$-2.9M
Q4 23
$-3.1M
Q3 23
$-2.1M
Gross Margin
ISPC
ISPC
RZLV
RZLV
Q2 25
44.4%
Q1 25
42.4%
Q4 24
13.5%
Q3 24
43.4%
Q2 24
51.9%
Q1 24
58.4%
Q4 23
44.6%
Q3 23
49.9%
Operating Margin
ISPC
ISPC
RZLV
RZLV
Q2 25
-255.4%
-808.4%
Q1 25
-154.9%
Q4 24
-395.8%
Q3 24
-64.1%
Q2 24
-76.2%
Q1 24
-131.0%
Q4 23
-111.5%
Q3 23
-79.0%
Net Margin
ISPC
ISPC
RZLV
RZLV
Q2 25
-146.9%
-1078.8%
Q1 25
-156.8%
Q4 24
-409.8%
Q3 24
-54.1%
Q2 24
-73.6%
Q1 24
-126.7%
Q4 23
-119.3%
Q3 23
-76.0%
EPS (diluted)
ISPC
ISPC
RZLV
RZLV
Q2 25
$-0.42
Q1 25
$-0.71
Q4 24
$-5.40
Q3 24
$-2.10
Q2 24
$-3.72
Q1 24
$-6.36
Q4 23
$-19.23
Q3 23
$-4.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISPC
ISPC
RZLV
RZLV
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$622.0K
$-14.3M
Total Assets
$6.0M
$80.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISPC
ISPC
RZLV
RZLV
Q2 25
Q1 25
Q4 24
$1.9M
Q3 24
$1.8M
Q2 24
$2.2M
Q1 24
$2.1M
Q4 23
$2.3M
Q3 23
$2.7M
Stockholders' Equity
ISPC
ISPC
RZLV
RZLV
Q2 25
$622.0K
$-14.3M
Q1 25
$1.7M
Q4 24
$3.3M
Q3 24
$4.7M
Q2 24
$6.1M
Q1 24
$6.8M
Q4 23
$9.7M
Q3 23
$12.7M
Total Assets
ISPC
ISPC
RZLV
RZLV
Q2 25
$6.0M
$80.1M
Q1 25
$6.8M
Q4 24
$9.4M
Q3 24
$11.3M
Q2 24
$11.9M
Q1 24
$12.5M
Q4 23
$15.8M
Q3 23
$16.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISPC
ISPC
RZLV
RZLV
Operating Cash FlowLast quarter
$-192.2K
$-4.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISPC
ISPC
RZLV
RZLV
Q2 25
$-192.2K
$-4.9M
Q1 25
$-1.1M
Q4 24
$-3.6M
Q3 24
$-1.1M
Q2 24
$-1.5M
Q1 24
$-2.1M
Q4 23
$345.1K
Q3 23
$-1.6M
Free Cash Flow
ISPC
ISPC
RZLV
RZLV
Q2 25
Q1 25
Q4 24
$-3.6M
Q3 24
$-1.1M
Q2 24
Q1 24
$-2.1M
Q4 23
Q3 23
$-1.6M
FCF Margin
ISPC
ISPC
RZLV
RZLV
Q2 25
Q1 25
Q4 24
-242.7%
Q3 24
-41.1%
Q2 24
Q1 24
-90.9%
Q4 23
Q3 23
-59.0%
Capex Intensity
ISPC
ISPC
RZLV
RZLV
Q2 25
Q1 25
Q4 24
0.5%
Q3 24
0.5%
Q2 24
0.0%
Q1 24
0.4%
Q4 23
0.0%
Q3 23
0.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons